BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3209911)

  • 1. [Distribution of oncotrophoblast antigens defined by monoclonal antibodies].
    Inoue R
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1837-43. PubMed ID: 3209911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The differentiation antigen of trophoblast expressed on trophoblastic neoplasms (choriocarcinoma and hydatidiform mole) detected by monoclonal antibodies].
    Nakamura T; Yamashita K
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Apr; 38(4):477-84. PubMed ID: 3701139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas.
    Sonoda K; Nakashima M; Kaku T; Kamura T; Nakano H; Watanabe T
    Cancer; 1996 Apr; 77(8):1501-9. PubMed ID: 8608535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
    Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
    Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to human choriocarcinoma.
    Yamashita K; Nakamura T; Shimizu T; Ohno H
    Am J Reprod Immunol Microbiol; 1986 Aug; 11(4):130-4. PubMed ID: 3532836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
    Suzuki H; Teshima K; Noda K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
    Ishiwata I; Ishiwata C
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):147-8. PubMed ID: 3855943
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
    Kimura E; Murae M; Koga R; Odawara Y; Nakabayashi Y; Yokoyama K; Nakata H; Totake T; Ochiai K; Yasuda M
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2121-8. PubMed ID: 6595320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tissue polypeptide antigen in gynecological cancer].
    Saitoh S; Nakanishi A; Noda T; Yoh S; Ando Y; Moriyama I; Ichijo M
    Gan No Rinsho; 1985 Jan; 31(1):65-72. PubMed ID: 3981803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New monoclonal antibody, 1C5, reactive with human cervical adenocarcinoma of the uterus, with immunodiagnostic potential.
    Koizumi M; Uede T; Shijubo N; Kudo R; Hashimoto M; Kikuchi K
    Cancer Res; 1988 Nov; 48(22):6565-72. PubMed ID: 3052807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a human cancer-associated antigen defined with monoclonal antibody.
    Bhattacharya M; Chatterjee SK; Barlow JJ
    Cancer Res; 1984 Oct; 44(10):4528-34. PubMed ID: 6380708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of CA 125 antigen levels in patients with ovarian cancer].
    Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
    Friedman EL; Hayes DF; Kufe DW
    Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of the monoclonal antibody to cultured uterine endometrial adenocarcinoma cells (EI)].
    Yudate T; Isaka K; Okabe K; Takayama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jul; 47(7):635-42. PubMed ID: 7636334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies.
    Tsuji Y; Suzuki T; Nishiura H; Takemura T; Isojima S
    Cancer Res; 1985 May; 45(5):2358-62. PubMed ID: 2580620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous distribution of acidic TA-4 in cervical squamous cell carcinoma: immunohistochemical demonstration with monoclonal antibodies.
    Kato H; Suehiro Y; Morioka H; Torigoe T; Myoga A; Sekiguchi K; Ikeda I
    Jpn J Cancer Res; 1987 Nov; 78(11):1246-50. PubMed ID: 3121560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum CA 125 and TPA determination in malignant neoplasms of the uterus].
    Gadducci A; Facchini V; Bartolini T; Fioretti P
    Ann Ostet Ginecol Med Perinat; 1988; 109(3):151-5. PubMed ID: 3207319
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunohistochemical demonstration of tumor antigen TA-4 in gynecologic tumors.
    Ueda G; Inoue Y; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Saito J; Nishino T; Abe Y
    Int J Gynecol Pathol; 1984; 3(3):291-8. PubMed ID: 6389386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93.
    Shitara K; Hanai N; Yoshida H
    Cancer Res; 1987 Mar; 47(5):1267-72. PubMed ID: 3545444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of CA-125 antigen (non-mucinous ovarian cancer antigen)-- in serum of patients with gynecological malignancies].
    Sakamoto S; Kawana H; Shimizu K; Ishihara T; Ueda K; Usman SM; Uchida S; Kawagoe K; Kihara K; Kubo H
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Aug; 36(8):1261-2. PubMed ID: 6595322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.